FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

900000000000509007: United States of America English language reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001115012 United States of America English language reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001116013 US English en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001117016 United States of America English language reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


1236119 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
US English Is a English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept) true Inferred relationship Some

Members acceptabilityId
150 minute serum GH level Preferred (foundation metadata concept)
150 minute serum GH level (procedure) Preferred (foundation metadata concept)
150 minute serum GH level (procedure) Preferred (foundation metadata concept)
150 minute serum GH measurement Preferred (foundation metadata concept)
150 minute serum LH level Preferred (foundation metadata concept)
150 minute serum LH level Preferred (foundation metadata concept)
150 minute serum LH level Acceptable (foundation metadata concept)
150 minute serum LH level (procedure) Preferred (foundation metadata concept)
150 minute serum LH level (procedure) Preferred (foundation metadata concept)
150 minute serum LH measurement Preferred (foundation metadata concept)
150 minute serum TSH level Preferred (foundation metadata concept)
150 minute serum TSH level Acceptable (foundation metadata concept)
150 minute serum TSH level Preferred (foundation metadata concept)
150 minute serum TSH level (procedure) Preferred (foundation metadata concept)
150 minute serum TSH level (procedure) Preferred (foundation metadata concept)
150 minute serum TSH measurement Acceptable (foundation metadata concept)
150 minute serum cortisol level Preferred (foundation metadata concept)
150 minute serum cortisol level Acceptable (foundation metadata concept)
150 minute serum cortisol level Preferred (foundation metadata concept)
150 minute serum cortisol level (procedure) Preferred (foundation metadata concept)
150 minute serum cortisol level (procedure) Preferred (foundation metadata concept)
150 minute serum cortisol measurement Preferred (foundation metadata concept)
150 minute serum cortisol measurement (procedure) Preferred (foundation metadata concept)
150 minute serum follicle stimulating hormone measurement Acceptable (foundation metadata concept)
150 minute serum follicle stimulating hormone measurement (procedure) Preferred (foundation metadata concept)
150 minute serum glucose level Preferred (foundation metadata concept)
150 minute serum glucose level Acceptable (foundation metadata concept)
150 minute serum glucose level Preferred (foundation metadata concept)
150 minute serum glucose level (procedure) Preferred (foundation metadata concept)
150 minute serum glucose level (procedure) Preferred (foundation metadata concept)
150 minute serum glucose measurement Preferred (foundation metadata concept)
150 minute serum glucose measurement (procedure) Preferred (foundation metadata concept)
150 minute serum growth hormone measurement Acceptable (foundation metadata concept)
150 minute serum growth hormone measurement (procedure) Preferred (foundation metadata concept)
150 minute serum luteinizing hormone measurement Acceptable (foundation metadata concept)
150 minute serum luteinizing hormone measurement (procedure) Preferred (foundation metadata concept)
150 minute serum prolactin level Acceptable (foundation metadata concept)
150 minute serum prolactin level Preferred (foundation metadata concept)
150 minute serum prolactin level Preferred (foundation metadata concept)
150 minute serum prolactin level (procedure) Preferred (foundation metadata concept)
150 minute serum prolactin level (procedure) Preferred (foundation metadata concept)
150 minute serum prolactin measurement Preferred (foundation metadata concept)
150 minute serum prolactin measurement (procedure) Preferred (foundation metadata concept)
150-Gd Acceptable (foundation metadata concept)
1500 Preferred (foundation metadata concept)
1500 (qualifier value) Preferred (foundation metadata concept)
15000 Preferred (foundation metadata concept)
15000 (qualifier value) Preferred (foundation metadata concept)
150000 Preferred (foundation metadata concept)
150000 (qualifier value) Preferred (foundation metadata concept)
1500000 Preferred (foundation metadata concept)
1500000 (qualifier value) Preferred (foundation metadata concept)
15000000 Preferred (foundation metadata concept)
15000000 (qualifier value) Preferred (foundation metadata concept)
151-Gd Acceptable (foundation metadata concept)
152-Gd Acceptable (foundation metadata concept)
152.4 Preferred (foundation metadata concept)
152.4 (qualifier value) Preferred (foundation metadata concept)
153-Gd Acceptable (foundation metadata concept)
153-Sm Acceptable (foundation metadata concept)
1537 U Preferred (foundation metadata concept)
154 Preferred (foundation metadata concept)
154 (qualifier value) Preferred (foundation metadata concept)
15885 Preferred (foundation metadata concept)
15885 (qualifier value) Preferred (foundation metadata concept)
159-Gd Acceptable (foundation metadata concept)
15Fr Acceptable (foundation metadata concept)
15M pre dose ornithine Acceptable (foundation metadata concept)
15q overgrowth syndrome Preferred (foundation metadata concept)
15q overgrowth syndrome (disorder) Preferred (foundation metadata concept)
15q partial monosomy syndrome Preferred (foundation metadata concept)
15q partial monosomy syndrome (disorder) Preferred (foundation metadata concept)
15q partial trisomy syndrome Preferred (foundation metadata concept)
15q partial trisomy syndrome (disorder) Preferred (foundation metadata concept)
15q11.2 microdeletion syndrome Preferred (foundation metadata concept)
15q11.2 microdeletion syndrome (disorder) Preferred (foundation metadata concept)
15q11q13 microduplication syndrome Preferred (foundation metadata concept)
15q11q13 microduplication syndrome (disorder) Preferred (foundation metadata concept)
15q13.3 deletion syndrome Acceptable (foundation metadata concept)
15q13.3 microdeletion Preferred (foundation metadata concept)
15q13.3 microduplication syndrome Preferred (foundation metadata concept)
15q13.3 microduplication syndrome (disorder) Preferred (foundation metadata concept)
15q14 microdeletion syndrome Preferred (foundation metadata concept)
15q14 microdeletion syndrome (disorder) Preferred (foundation metadata concept)
15q24 deletion Acceptable (foundation metadata concept)
15q24 microdeletion Preferred (foundation metadata concept)
15q24 microdeletion syndrome Acceptable (foundation metadata concept)
15q26 deletion syndrome Acceptable (foundation metadata concept)
15q26.3 microdeletion syndrome Acceptable (foundation metadata concept)
16 Preferred (foundation metadata concept)
16 (qualifier value) Preferred (foundation metadata concept)
16 Personality factor questionnaire Preferred (foundation metadata concept)
16 Personality factor questionnaire (assessment scale) Preferred (foundation metadata concept)
16 alpha-hydroxydehydroepiandrosterone Preferred (foundation metadata concept)
16 alpha-hydroxydehydroepiandrosterone (substance) Preferred (foundation metadata concept)
16 alpha-hydroxydehydroepiandrosterone sulfate Preferred (foundation metadata concept)
16 alpha-hydroxydehydroepiandrosterone sulfate (substance) Preferred (foundation metadata concept)
16 alpha-hydroxyestrone Preferred (foundation metadata concept)
16 alpha-hydroxyestrone (substance) Preferred (foundation metadata concept)
16 times a day Acceptable (foundation metadata concept)
16-alpha-Hydroxypregnenolone Preferred (foundation metadata concept)

Start Previous Page 71 of 12362 Next End


Reference Sets

Reference set descriptor

Back to Start